Carol Karp
Consigliere Generale presso PROTHENA CORPORATION PLC
Patrimonio netto: - $ in data 31/05/2024
Posizioni attive di Carol Karp
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| PROTHENA CORPORATION PLC | Consigliere Generale | 15/12/2016 | - |
| Rochester Christian University | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Carol Karp
Precedenti posizioni note di Carol Karp
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ESPERION THERAPEUTICS, INC. | Responsabile della Conformità | 01/01/2013 | 01/01/2014 |
| Consigliere Generale | 01/01/2013 | 01/01/2014 | |
| Janssen Alzheimer Immunotherapy | Consigliere Generale | 01/01/2010 | 01/01/2013 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Consigliere Generale | - | 02/05/2011 |
| VIVUS, INC. | Corporate Officer/Principal | - | - |
| Powderject Technologies BV | Direttore Tecnico/Scientifico/R&S | - | - |
Formazione di Carol Karp
| Rochester Christian University | Undergraduate Degree |
| New York University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
| Paesi Bassi | 2 |
| Irlanda | 2 |
Posizioni
| General Counsel | 4 |
| Undergraduate Degree | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ESPERION THERAPEUTICS, INC. | Health Technology |
| PROTHENA CORPORATION PLC | Health Technology |
| Aziende private | 4 |
|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
| Powderject Technologies BV | |
VIVUS, Inc.
 VIVUS, Inc. Pharmaceuticals: MajorHealth Technology VIVUS, Inc. engaged in the development and commercialization of novel therapeutic products. The firm’s products were indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and it was headquartered in Campbell, CA. | Health Technology |
| Janssen Alzheimer Immunotherapy |
- Borsa valori
- Insiders
- Carol Karp
- Esperienza
